Synthesis, Antimicrobial Capability and Molecular Docking of Heterocyclic Scaffolds Clubbed by 2-Azetidinone, Thiazole and Quinoline Derivatives

References

• Parul D. Mehta, Nidhi P. S. Sengar, and Anupam K. Pathak, “2-Azetidinone-a New Profile of Various Pharmacological Activities,”European Journal of Medicinal Chemistry 45, no. 12 (2010): 5541–60.
   PubMed Web of Science ®Google Scholar
• Ahmed N. Ayyash, “Synthesis and Antimicrobial Screening of Novel Azetidin-2-Ones Derived from Pyromellitic Diimide via [2 + 2]-Cycloaddition Reaction,”Russian Journal of Organic Chemistry 55, no. 12 (2019): 1961–6.
   Web of Science ®Google Scholar
• Paola Galletti, Roberto Soldati, Matteo Pori, Margherita Durso, Alessandra Tolomelli, Luca Gentilucci, Samantha D. Dattoli, Monica Baiula, Santi Spampinato, and Daria Giacomini, “Targeting Integrins αvβ3 and α5β1 with New β-Lactam Derivatives,” European Journal of Medicinal Chemistry 83, (2014) : 284–93.
   PubMed Web of Science ®Google Scholar
• Deb R. Banerjee, Rupam Biswas, Amit K. Das, and Amit Basak, “Design, Synthesis and Characterization of Dual Inhibitors against New Targets FabG4 and HtdX of Mycobacterium tuberculosis,” European Journal of Medicinal Chemistry 100 (2015): 223–34.
   PubMed Web of Science ®Google Scholar
• Azizah M. Malebari, Darren Fayne, Seema M. Nathwani, Fiona O'Connell, Sara Noorani, Brendan Twamley, Niamh M. O'Boyle, Jacintha O'Sullivan, Daniela M. Zisterer, and Mary J. Meegan, “β-Lactams with Antiproliferative and Antiapoptotic Activity in Breast and Chemoresistant Colon Cancer Cells,” European Journal of Medicinal Chemistry 189 (2020): 112050.
   PubMed Web of Science ®Google Scholar
• Roghayeh Heiran, Saghi Sepehri, Aliasghar Jarrahpour, Carole Digiorgio, Hana Douafer, Jean M. Brunel, Ahmad Gholami, Elham Riazimontazer, and Edward Turos, “Synthesis, Docking and Evaluation of in Vitro anti-Inflammatory Activity of Novel Morpholine Capped β-Lactam Derivatives,” Bioorganic Chemistry 102 (2020): 104091.
   PubMed Web of Science ®Google Scholar
• William C. Patt, Harriet W. Hamilton, Michael D. Taylor, Michael J. Ryan, David G. Taylor, Jr., Cleo J. C. Connolly, Annette M. Doherty, Sylvester R. Klutchko, Ila Sircar, Bruce A. Steibaugh, et al. “Structure-Activity Relationships of a Series of 2-Amino-4-Thiazole-Containing Renin Inhibitors” Journal of Medicinal Chemistry 35, no. 14 (1992): 2562–72.
   PubMed Web of Science ®Google Scholar
• Juan C. Jaen, Lawrence D. Wise, Bradley W. Caprathe, Haile Tecle, Stephen Bergmeier, Christine C. Humblet, Thomas G. Heffner, Leonard T. Meltzer, and Thomas A. Pugsley, “4-(1,2,5,6-Tetrahydro-1-Alkyl-3-Pyridinyl)-2-Thiazolamines: A Novel Class of Compounds with Central Dopamine Agonist Properties,”Journal of Medicinal Chemistry 33, no. 1 (1990): 311–7.
   PubMed Web of Science ®Google Scholar
• Koichi Tsuji, and Hiroshi Ishikawa, “Synthesis and Anti-Pseudomonal Activity of New 2-Isocephems with a Dihydroxypyridone Moiety at C-7,”Bioorganic & Medicinal Chemistry Letters 4, no. 13 (1994): 1601–6.
   Web of Science ®Google Scholar
• Frank W. Bell, Amanda S. Cantrell, Marita Hoegberg, S. Richard Jaskunas, Nils Gunnar Johansson, Christopher L. Jordan, Michael D. Kinnick, Peter Lind, John M. Morin, Jr., Rolf Noreen, et al. “Phenethylthiazolethiourea (PETT) Compounds, a New Class of HIV-1 Reverse Transcriptase Inhibitors. 1. Synthesis and Basic Structure-Activity Relationship Studies of PETT Analogs,”Journal of Medicinal Chemistry 38, no. 25 (1995): 4929–36.
   PubMed Web of Science ®Google Scholar
• Nedime Ergenç, Gültaze Çapan, Nur S. Günay, Sumru Özkirimli, Mehmet Güngör, Süheyla Özbey, and Engin Kendi, “Synthesis and Hypnotic Activity of New 4-Thiazolidinone and 2-Thioxo-4,5-Imidazolidinedione Derivatives,”Archiv Der Pharmazie 332, no. 10 (1999): 343–7.
   PubMed Web of Science ®Google Scholar
• Jeffery S. Carter, Steven Kramer, John J. Talley, Thomas Penning, Paul Collins, Matthew J. Graneto, Karen Seibert, Carol M. Koboldt, Jaime Masferrer, and Ben Zweifel, “Synthesis and Activity of Sulfonamide-Substituted 4,5-Diaryl Thiazoles as Selective Cyclooxygenase-2 Inhibitors,”Bioorganic & Medicinal Chemistry Letters 9, no. 8 (1999): 1171–4.
   PubMed Web of Science ®Google Scholar
• Alain Badorc, Marie-Françoise Bordes, Paul de Cointet, Pierre Savi, André Bernat, Alain Lalé, Maurice Petitou, Jean-Pierre Maffrand, and Jean-Marc Herbert, “New Orally Active Non-Peptide Fibrinogen Receptor (GpIIb-IIIa) Antagonists: Identification of Ethyl-3-[N-[4-[4-[Amino[(Ethoxycarbonyl)Imino]Methyl]Phenyl]-1,3-Thiazol-2-Yl]-N-[1-[(Ethoxycarbonyl)Methyl]Piperid-4-Yl]Amino]Propionate (SR 121787) as a Potent and Long-Acting Antithrombotic Agent,” Journal of Medicinal Chemistry 40 (1997): 3393–401.
   PubMed Web of Science ®Google Scholar
• Joachim Rudolph, Heidi Theis, Roman Hanke, Rainer Endermann, Lars Johannsen, and Frank-Ulrich Geschke, “seco-Cyclothialidines: New Concise Synthesis, Inhibitory Activity toward Bacterial and Human DNA Topoisomerases, and Antibacterial Properties,” Journal of Medicinal Chemistry 44, no. 4 (2001): 619–26.
   PubMed Web of Science ®Google Scholar
• Aness A. Siddiqui, Sangh Partap, Subuhi Khisal, Mohammad S. Yar, and Ravinesh Mishra, “Synthesis, Anti-Convulsant Activity and Molecular Docking Study of Novel Thiazole Pyridazinone Hybrid Analogues,” Bioorganic Chemistry 99 (2020): 103584.
   PubMed Web of Science ®Google Scholar
• Thoraya A. Farghaly, Ghada S. Masaret, Zeinab A. Muhammad, and Marwa F. Harras, “Discovery of Thiazole-Based-Chalcones and 4-Hetarylthiazoles as Potent Anticancer Agents: Synthesis, Docking Study and Anticancer Activity,” Bioorganic Chemistry 98 (2020): 103761.
   PubMed Web of Science ®Google Scholar
• Mohamed R. Shaaban, Thoraya A. Farghaly, and Amani M. R. Alsaedi, “Synthesis, Antimicrobial and Anticancer Evaluations of Novel Thiazoles Incorporated Diphenyl Sulfone Moiety,” Polycyclic Aromatic Compounds (2020).
   Web of Science ®Google Scholar
• Mohammed T.-E. Maghraby, Ola M. F. Abou-Ghadir, Samia G. Abdel-Moty, Asmaa Y. Ali, and Ola I. A. Salem, “Novel Class of Benzimidazole-Thiazole Hybrids: The Privileged Scaffolds of Potent anti-Inflammatory Activity with Dual Inhibition of Cyclooxygenase and 15-Lipoxygenase Enzymes,” Bioorganic & Medicinal Chemistry 28, no. 7 (2020): 115403.
   PubMed Web of Science ®Google Scholar
• Cleudiomar I. Lino, Igor G. de Souza, Beatriz M. Borelli, Thelma T. S. Matos, Iasmin N. S. Teixeira, Jonas P. Ramos, Elaine M. de Souza Fagundes, Philipe de Oliveira Fernandes, Vinicius G. Maltarollo, Susana Johann, et al. “Synthesis, Molecular Modeling Studies and Evaluation of Antifungal Activity of a Novel Series of Thiazole Derivatives,” European Journal of Medicinal Chemistry 151 (2018): 248–60.
   PubMed Web of Science ®Google Scholar
• Suresh Kumar, Sandhya Bawa, and Himanshu Gupta, “Biological Activities of Quinoline Derivatives,”Mini Reviews in Medicinal Chemistry 9, no. 14 (2009): 1648–54.
   PubMed Web of Science ®Google Scholar
• Mohamed Abass, Abdel R. A. Alzandi, Mohamed M. Hassan, and Noha Mohamed, “Recent Advances on Diversity Oriented Heterocycle Synthesis of Fused Quinolines and Its Biological Evaluation,” Polycyclic Aromatic Compounds (2020).
   Web of Science ®Google Scholar
• Jingyu Zhang, Su Wang, Yanyan Ba, and Zhi Xu, “1,2,4-Triazole-Quinoline/Quinolone Hybrids as Potential Anti-Bacterial Agents,” European Journal of Medicinal Chemistry 174 (2019): 1–8.
   PubMed Web of Science ®Google Scholar
• Nisheeth C. Desai, Bonny Y. Patel, and Bharti P. Dave, “Synthesis and Antimicrobial Activity of Novel Quinoline Derivatives Bearing Pyrazoline and Pyridine Analogues,”Medicinal Chemistry Research 26, no. 1 (2017): 109–19.
   Web of Science ®Google Scholar
• Peng Teng, Chunhui Li, Zhong Peng, Anne Marie, Vanderschouw, Alekhya Nimmagadda, Ma Su, Yaqiong Li, Xingmin Sun, and Jianfeng Cai, “Facilely Accessible Quinoline Derivatives as Potent Antibacterial Agents,” Bioorganic & Medicinal Chemistry 26, no. 12 (2018): 3573–9.
   PubMed Web of Science ®Google Scholar
• Fatma A. Bassyouni, Sherifa M. Abu-Baker, Khaled Mahmoud, Maysa Moharam, Sally S. El-Nakkady, and Mohamed A. Rehim, “Synthesis and Biological Evaluation of Some New Triazolo[1,5-a] Quinoline Derivatives as Anticancer and Antimicrobial Agents,”RSC Advances 4, no. 46 (2014): 24131–41.
   Web of Science ®Google Scholar
• Mostafa H. Abdelrahman, Bahaa G. M. Youssif, Mohamed A. Abdelgawad, Ahmed H. Abdelazeem, Hussein M. Ibrahim, Abd El G. A. Moustafa, Laurent Treamblu, and Syed N. A. Bukhari, “Synthesis, Biological Evaluation, Docking Study and Ulcerogenicity Profiling of Some Novel Quinoline-2-Carboxamides as Dual COXs/LOX Inhibitors Endowed with Anti-Inflammatory Activity,” European Journal of Medicinal Chemistry 127 (2017): 972–85.
   PubMed Web of Science ®Google Scholar
• Ana F. Borsoi, Josiane D. Paz, Bruno L. Abbadi, Fernanda S. Macchi, Nathalia Sperotto, Kenia Pissinate, Raoní S. Rambo, Alessandro S. Ramos, Diana Machado, Miguel Viveiros, et al. “Design, Synthesis, and Evaluation of New 2-(Quinoline-4-yloxy)Acetamide-Based Antituberculosis Agents,” European Journal of Medicinal Chemistry 192 (2020): 112179.
   PubMed Web of Science ®Google Scholar
• Rahul V. Patel, Premlata Kumari, Dhanji Rajani, and Kishor H. Chikhalia, “Synthesis and Studies of Novel 2-(4-Cyano-3-Trifluoromethylphenyl Amino)-4-(Quinoline-4-yloxy)-6-(Piperazinyl/Piperidinyl)-s-Triazines as Potential Antimicrobial, Antimycobacterial and Anticancer Agents,” European Journal of Medicinal Chemistry 46, no. 9 (2011): 4354–65.
   PubMed Web of Science ®Google Scholar
• Dina I. A. Othman, Khalid B. Selim, Magda A.-A. El-Sayed, Atif S. Tantawy, Yhiya Amen, Kuniyoshi Shimizu, Tatsuo Okauchi, and Mitsuru Kitamura, “Design, Synthesis and Anticancer Evaluation of New Substituted Thiophene-Quinoline Derivatives,” Bioorganic & Medicinal Chemistry 27, no. 19 (2019): 115026.
   PubMed Web of Science ®Google Scholar
• Christophe Bénard, Fatima Zouhiri, Marie Normand-Bayle, Michèle Danet, Didier Desmaële, Hervé Leh, Jean-François Mouscadet, Gladys Mbemba, Claire-Marie Thomas, Sabine Bonnenfant, et al. “Linker-Modified Quinoline Derivatives Targeting HIV-1 Integrase: Synthesis and Biological Activity,” Bioorganic & Medicinal Chemistry Letters 14, no. 10 (2004): 2473–6.
   PubMed Web of Science ®Google Scholar
• Niamh Dolan, Declan P. Gavin, Ahmed Eshwika, Kevin Kavanagh, John McGinley, and John C. Stephens, “Synthesis, Antibacterial and Anti-MRSA Activity, in Vivo Toxicity and a Structure-Activity Relationship Study of a Quinoline Thiourea,”Bioorganic & Medicinal Chemistry Letters 26, no. 2 (2016): 630–5.
   PubMed Web of Science ®Google Scholar
• Thu D. M. Pham, Zyta M. Ziora, and Mark A. T. Blaskovich, “Quinolone Antibiotics,” Medicinal Chemistry Communications 10, no. 10 (2019): 1719–39.
   Google Scholar
• Jose L. Martinez, “Mechanisms of Action and of Resistance to Quinolones,” in Antibiotic Drug Resistance,” ed. (Hoboken, NJ: John Wiley & Sons, 2019), 39–55.
   Google Scholar
• Elizabeth G. Gibson, “Overcoming Fluoroquinolone Resistance: Mechanistic Basis of Non-Quinolone Antibacterials Targeting Type II Topoisomerases” (PhD, Tennessee. US: Vanderbilt University, 2019).
   Google Scholar
• Ranjan Aggarwal, Sunil Kumar, Pawan Kaushik, Dhirender Kaushik, and Girish K. Gupta, “Synthesis and Pharmacological Evaluation of Some Novel 2-(5-Hydroxy-5-Trifluoromethyl-4,5-Dihydropyrazol-1-Yl)-4-(Coumarin-3-Yl)Thiazoles,” European Journal of Medicinal Chemistry 62 (2013): 508–14.
   PubMed Web of Science ®Google Scholar
• Nisheeth C. Desai, Vivek V. Joshi, Kiran M. Rajpara, Hasit V. Vaghani, and Hitesh M. Satodiya, “Synthesis of Quinoline-Pyrazoline Based Thiazole Derivatives Endowed with Antimicrobial Activity,” Indian Journal of Chemistry 52B (2013): 1191–201.
   Google Scholar
• Nisheeth C. Desai, and Amit M. Dodiya, “Synthesis, Characterization and in Vitro Antimicrobial Screening of Quinoline Nucleus Containing 1,3,4-Oxadiazole and 2-Azetidinone Derivatives,”Journal of Saudi Chemical Society 18, no. 5 (2014): 425–31.
   Web of Science ®Google Scholar
• Gundibasappa K. Nagaraja, Gowdara K. Prakash, Marlingaplara N. Kumaraswamy, Vijayavittala P. Vaidya, and Kittappa M. Mahadevan, “Synthesis of Novel Nitrogen Containing Naphtho[2,1-b]Furan Derivatives and Investigation of Their Anti Microbial Activities,”Arkivoc 2006, no. 15 (2006): 160–8.
   Google Scholar
• Mohd I. Ansari, and Suroor A. Khan, “Synthesis and Antimicrobial Activity of Some Novel Quinolinepyrazoline-Based Coumarinyl Thiazole Derivatives,” Medicinal Chemistry Research 26, no. 7 (2017): 1481–96.
   Web of Science ®Google Scholar
• Ashraf A. Aly, Asmaa H. Mohamed, and Mohamed Ramadan, “Synthesis and Colon Anticancer Activity of Some Novel Thiazole/-2-Quinolone Derivatives,” Journal of Molecular Structure 1207 (2020): 127798.
   Web of Science ®Google Scholar
• National Committee for Clinical Laboratory, Standards Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Approved Standard, 3rd ed. (Villanova, PA: NCCLS Publication, 1993).
   Google Scholar
• National Committee for Clinical Laboratory Standards, Reference Method for Broth Dilution Antifungal Testing of Yeasts, Proposed Standard, NCCLS Document M27-P (Villanova, PA, 1992).
   Google Scholar
• Otto Meth-Cohn, “The Synthesis of Pyridines, Quinolines and Other Related Systems by the Vilsmeier and the Reverse Vilsmeier Method,” Heterocycles 35, no. 1 (1993): 539–57.
   Web of Science ®Google Scholar
• Richard A. Friesner, Robert B. Murphy, Matthew P. Repasky, Leah L. Frye, Jeremy R. Greenwood, Thomas A. Halgren, Paul C. Sanschagrin, and Daniel T. Mainz, “Extra Precision Glide:  Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for protein-ligand complexes,” Journal of Medicinal Chemistry 49, no. 21 (2006): 6177–96.
   PubMed Web of Science ®Google Scholar
• Richard A. Friesner, Jay L. Banks, Robert B. Murphy, Thomas A. Halgren, Jasna J. Klicic, Daniel T. Mainz, Matthew P. Repasky, Eric H. Knoll, Mee Shelley, Jason K. Perry, et al. “Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy,”Journal of Medicinal Chemistry 47, no. 7 (2004): 1739–49.
   PubMed Web of Science ®Google Scholar
• Thomas A. Halgren, Robert B. Murphy, Richard A. Friesner, Hege S. Beard, Leah L. Frye, W. Thomas Pollard, and Jay L. Banks, “Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening,” Journal of Medicinal Chemistry 47, no. 7 (2004): 1750–9.
   PubMed Web of Science ®Google Scholar
• Xiayang Qiu, Cheryl A. Janson, Ward W. Smith, Martha Head, John Lonsdale, and Alex K. Konstantinidis, “Refined Structures of Beta-Ketoacyl-Acyl Carrier Protein Synthase III,” Journal of Molecular Biology 307, no. 1 (2001): 341–56.
   PubMed Web of Science ®Google Scholar